QYM with IVD Reagent Company to Visit Hospital Clinical Laboratories

On Jan. 28, Sam, the Business Director of QYM/SURFTECH, together with cooperative reagent enterprises, visited clinical laboratories of the Infectious Disease Campus, Anhui Provincial Hospital (Grade A tertiary hospitals) for technical exchanges, breaking barriers among substrate R&D, reagent production and clinical application.

During exchanges, the three parties discussed key clinical testing pain points in depth. Clinical laboratories noted the core impact of substrate stability and reaction sensitivity on testing accuracy, with QYM and IVD Reagent Company answering questions on-site and recording clinical needs.

As a IVD substrates supplier, QYM adheres to clinical demand-oriented R&D. This visit helps it capture new substrate performance requirements accurately, supporting reagent enterprises to develop clinical-adapted products.

Going forward, the three parties will deepen cooperation. QYM will optimize substrate formulas and processes, empower IVD reagent upgrading with high-quality raw materials, improve diagnostic efficiency of clinical laboratories and safeguard patient diagnosis and treatment.